TPST 8-K 2026-10-30

Tempest Therapeutics, Inc. (TPST) 8-K dated 2026-10-30 — accession 0001213900-26-114376.

Tempest Therapeutics, Inc. (TPST) is a biotechnology company listed on US.

Tempest Therapeutics, Inc. filed a 8-K on 2026-10-30. Accession 0001213900-26-114376.

This 8-K covers: Director/officer change (Item 5.02). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for TPST is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The TPST SEC hub lists recent forms. The stock page is the research view.